Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
The Prostate|May 21, 2016
Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cellsRavikumar Muthuswamy, John M Corman, Kathryn Dahl, et al.
Journal of Leukocyte Biology|April 23, 2008
Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemiaJe-Jung Lee, Kenneth A Foon, Robbie B Mailliard, et al.
Immunologic Research|March 6, 2007
Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccinesPawel Kalinski, Yutaro Nakamura, Payal Watchmaker, et al.
Cancer Research|July 18, 2008
Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturationRavikumar Muthuswamy, Julie Urban, Je-Jung Lee, et al.
Blood|May 26, 2010
PGE(2) transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cellsRavikumar Muthuswamy, Jan Mueller-Berghaus, Uwe Haberkorn, et al.
Nature Protocols|January 19, 2018
Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agentsNataša Obermajer, Julie Urban, Eva Wieckowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 19, 2009
Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cellsPayal B Watchmaker, Erik Berk, Ravikumar Muthuswamy, et al.
Cancer Research|November 8, 2011
Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNANaoki Umemura, Jianzhong Zhu, Yvonne K Mburu, et al.
Cancer Research|May 18, 2012
NF-κB hyperactivation in tumor tissues allows tumor-selective reprogramming of the chemokine microenvironment to enhance the recruitment of cytolytic T effector cellsRavikumar Muthuswamy, Erik Berk, Beth Fallert Junecko, et al.
Cancer Research|February 5, 2009
Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10Mitsugu Fujita, Xinmei Zhu, Ryo Ueda, et al.
Pageof 3